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Abstract
Previous studies have shown that the vascular reactivity of the mouse
aorta differs substantially from that of the rat aorta in response to
several agonists such as angiotensin II, endothelin-1 and isoprote-
renol. However, no information is available about the agonists brady-
kinin (BK) and DesArg9BK (DBK). Our aim was to determine the
potential expression of kinin B1 and B2 receptors in the abdominal
mouse aorta isolated from C57BL/6 mice. Contraction and relaxation
responses to BK and DBK were investigated using isometric record-
ings. The kinins were unable to induce relaxation but concentration-
contraction response curves were obtained by applying increasing
concentrations of the agonists BK and DBK. These effects were
blocked by the antagonists Icatibant and R-715, respectively. The
potency (pD2) calculated from the curves was 7.0 ± 0.1 for BK and 7.3
± 0.2 for DBK. The efficacy was 51 ± 2% for BK and 30 ± 1% for DBK
when compared to 1 µM norepinephrine. The concentration-depend-
ent responses of BK and DBK were markedly inhibited by the
arachidonic acid inhibitor indomethacin (1 µM), suggesting a media-
tion by the cyclooxygenase pathway. These contractile responses
were not potentiated in the presence of the NOS inhibitor L-NAME (1
mM) or endothelium-denuded aorta, indicating that the NO pathway
is not involved. We conclude that the mouse aorta constitutively
contains B1 and B2 subtypes of kinin receptors and that stimulation
with BK and DBK induces contractile effect mediated by endothe-
lium-independent vasoconstrictor prostanoids.
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Introduction
Kinins are proinflammatory peptides that
act as local hormones and activate the re-
lease of endothelium-derived relaxing fac-
tors such as nitric oxide (NO) and prosta-
glandins, increase vascular permeability, re-
lax or contract smooth muscle, and provoke
pain (for a review, see Ref. 1). Most of these
effects of kinins are mediated by the activa-
tion of the B2 receptor, which belongs to a
family of peptide hormone receptors linked
to G proteins, via the agonist bradykinin
(BK).
Another kinin receptor, the B1 receptor,
is activated by the agonist DesArg9BK (DBK)
and is generally absent or expressed at very
low levels in healthy tissues but is induced in
650
Braz J Med Biol Res 40(5) 2007
S.A. Felipe et al.
www.bjournal.com.br
response to pathological insults and medi-
ates cardiovascular and nociceptive re-
sponses in these conditions (2). It has been
shown that the mouse stomach fundus con-
stitutively expresses kinin B1 and B2 recep-
tors (3) but no data regarding mouse vascu-
lar reactivity to kinins have been reported.
Therefore, our aim was to characterize
pharmacologically the expression of B1 and
B2 subtypes of kinin receptors in the mouse
aorta through isometric contractions and us-
ing antagonists for these receptors. In this
study we demonstrate that BK and DBK did
not relax but induced endothelium-independ-
ent contractions of mouse abdominal aorta
in a concentration-dependent fashion. These
contractile responses to the kinins in rings of
abdominal aorta were associated with the
production of eicosanoids, whereas NO in-
volvement was not demonstrable.
Material and Methods
Animals and organ preparations
The protocols used in the present study
were in accordance with current guidelines for
the care of laboratory animals and ethical
guidelines for investigations, and were ap-
proved by the Animal Care Committee of the
Federal University of São Paulo. Animals were
maintained on standard mouse chow at 21-
23ºC and kept on a 12-h light:dark cycle, with
free access to food and water. After 12-16
weeks of age, the animals, weighing 26-30 g,
were killed by cervical dislocation and exsan-
guination. The thoracic and abdominal aortas
were removed, cleared of connective tissue
and mounted as ring preparations using 40-
mm tungsten wire, into 5-mL organ baths.
Aortic rings were bathed in carboxygenated
(95% O2/5% CO2) modified Krebs-Ringer so-
lution (144 mM NaCl, 5 mM KCl, 1.1 mM
MgSO4, 25 mM NaHCO3, 1.1 mM NaH2PO4,
1.25 mM CaCl, and 5.5 mM glucose), pH
7.35, at 37ºC. Resting tension was maintained
at 0.5 g. Tissues were left to equilibrate for 1 h,
with frequent changes of bathing solution.
Tissue viability was assessed by priming with
80 mM KCl and 1 µM norepinephrine (NE).
Following a 90-min washout and recovery
period, cumulative or non-cumulative con-
centration-response curves to the agonists were
determined. Changes in tension produced by
the stimulants were measured with an isomet-
ric transducer (FTA-10) through an amplifier
(E805, Hewlett-Packard, Palo Alto, CA, USA)
and a potentiometric recorder (RB-102, ECB,
São Paulo, SP, Brazil), as described previ-
ously (4). Concentration-response curves were
constructed for BK and DBK by applying
from 0.1 nM to 1 µM agonist concentrations.
In some experiments, these curves were ob-
tained in the absence and in the presence of
specific inhibitors. To determine the apparent
affinity of agonists in terms of pD2 (the nega-
tive logarithm of the concentration of agonist
that produces 50% of the maximal effect) the
curve-fitting analysis of the dose-response
curves was carried out using the GraphPad-
Prism software (San Diego, CA, USA). Data
are reported as means ± SD.
Analysis of gene expression
Analysis of gene expression for kinin B1
and B2 receptors was carried out using real-
time quantitative PCR. Five mice were killed
and their aortas were isolated, dissected,
frozen in liquid nitrogen and stored at -80ºC.
Frozen tissue was homogenized in 1 mL
TRIzol reagent (Invitrogen, Carlsbad, CA,
USA) and total RNA was isolated according
to manufacturer instructions. Samples were
submitted to a 20-µL reaction using the
TaqMan® amplification system with an ABI
PRISM® 7000 sequence detection system
(Applied Biosystems, Foster City, CA, USA).
Real-time PCR was performed with a 1:10
dilution sample of cDNA obtained from to-
tal RNA with the SuperScricpt™ III first-
strand synthesis SuperMix for qRT-PCR (In-
vitrogen) for kinin B1 and B2 receptors and
ß-actin was used as an internal standard.
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Oligonucleotide primer and fluorogenic
probe sets for Taqman™ Real-time PCR
were designed for kinin receptors and ß-
actin using the Assays-by-Design Service
(Applied Biosystems) to meet all TaqMan®
design guidelines. Probes were synthesized
with the reporter dye 6-carboxyfluorescein
covalently linked at the 5' end and the
quencher dye 6-carboxy-tetramethyl-rhoda-
mine was linked to the 3' end of the probe.
Each reaction was carried out with 10 µL of
Master Mix (Applied Biosystems), 1 µL of a
mix containing two primers (18 µM each)
and a probe (5 µM) specific for mRNA of the
kinin B1 receptor (probe 5'-CACAGGAAC
CCCAGACAGA-3', forward primer 5'-CTC
CATACAAAACCCCAGCTGAA-3', re-
verse primer 5'-CTTTGGTTAGAAGGCTG
TAGCTTCA-3'), kinin B2 receptor (probe
5'-CTTTGGCATCGAAATGT-3', forward
primer 5'-GGTTTCTGTCGGTGCATGA
G-3', reverse primer 5'-GGACTTGTGTGGT
GACGTTGA-3') or ß-actin (probe 5'-CA
GATCATGTTTGAGACCTT-3', forward
primer 5'-GGCCAACCGTGAAAAGATGA
C-3', reverse primer 5'-GCCTGGATGGCT
ACGTACATG-3'), 5 µL of cDNA samples
and Milli-Q water (Millipore Corporation,
Billerica, MA, USA) to 20 µL. The cycle
conditions were: 50ºC for 2 min, 95ºC for 10
min, followed by 50 cycles of 95ºC for 15 s
(melting step), 60ºC for 1 min (anneal/ex-
tend step). Increases in the amount of re-
porter dye fluorescence during the 50 ampli-
fication cycles were monitored using Se-
quence Detector software (SDS version 1.6,
Applied Biosystems). The PCR cycle when
a given fluorescence threshold is crossed by
the amplification curve is considered to be
the first parameter analyzing mRNA expres-
sion and is named CT. The larger the initial
amount of copies, the lower the CT number.
A normalized value is obtained by subtract-
ing CT of kinin B1 or B2 receptor from CT of
ß-actin, resulting in ∆CT. Since it is uncom-
mon to use ∆CT as a relative expression
parameter due to this logarithmic character-
istic, the 2-∆CT parameter was used to express
the relative gene expression data.
Drugs
BK and DBK were obtained from Bachem
(Torrance, CA, USA); Icatibant (Aventis,
Frankfurt, Germany) and R-715 were a gift
from D. Regoli, Université de Sherbrooke,
Quebec (Canada). DesArg9Leu8BK was syn-
thesized in the Department of Biophysics,
Federal University of São Paulo, São Paulo,
SP, Brazil. Other reagents were purchased
from Sigma Chemical Co. (Dorset, UK).
TRIzol reagent and SuperScricpt™ III First-
Strand Synthesis SuperMix for qRT-PCR were
purchased from Invitrogen; TaqMan® Real-
Time PCR primers and Master Mix for
TaqMan® Real-Time PCR were from Applied
Biosystems. Concentrated solutions of pep-
tides (1 mg/mL) and other agents were pre-
pared in water and kept at -20ºC until used.
The stock solutions were serially diluted with
Krebs-Ringer solution. Indomethacin solutions
were prepared just before use by dissolving
the drug in a small volume of saturated aque-
ous sodium carbonate, diluting to the desired
volume with Krebs-Ringer solution. The ve-
hicle used for the administration of indometh-
acin had no effect on the responses of the
isolated tissue to agonists. All solutions were
adjusted to pH 7.35 before use.
Statistical analysis
Values are reported as means ± SD. The
Student t-test or analysis of variance
(ANOVA) with multiple comparisons was
used to determine the statistical differences,
with the level of significance set as P < 0.05.
Results
BK and DBK were able to promote con-
tractile responses in the aortic rings. The pD2
values of BK and DBK calculated from con-
centration-response curves (Figure 1) indi-
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cated that the potency was similar but the
efficacy of BK was significantly higher than
that of DBK (Table 1). These effects of BK
and DBK were shown to be independent of
the presence of the endothelium. The re-
moval of the endothelium was confirmed by
the lack of acetylcholine-induced relaxation
of abdominal aorta precontracted with 1 µM
NE.
In the presence of 1 µM Icatibant pre-
incubated for 30 min, BK-induced contrac-
tion of abdominal aorta was drastically in-
hibited, whereas the DBK-induced effect
was blocked by 1 µM R-715. A peptide an-
tagonist of the B1 receptor, 1 µM
DesArg9Leu8BK preincubated for 30 min,
had a similar effect (data not shown). Most
results were obtained with R-715 since its
effect was rapidly reversible. The results
obtained with Icatibant and R-715 are shown
in Figure 2.
Figure 1. Cumulative concentration-response curves
for the effects of bradykinin (BK) and Des-Arg9BK
(DBK), agonists of kinin B2 and B1 receptors, respec-
tively, on rings of abdominal aorta isolated from mice.
The isometric contraction responses were calculated in
relation to the maximal effect of 1 µM norepinephrine
(NE) which was considered to be 100%. Data are re-
ported as the means ± SD of 5 experiments. *P < 0.05
compared to BK (ANOVA).
Figure 2. Effect of antagonists of the kinin B2 receptor, 1 µM Icatibant and of the B1 receptor, 1 µM R-715, on abdominal
aortic rings isolated from mice. Cumulative concentration-response curves for bradykinin (BK) (A) and Des-Arg9BK
(DBK) (B) were determined in the presence and absence of the respective antagonists. The isometric contraction
responses were calculated in relation to the maximal effect of 1 µM norepinephrine (NE) which was considered to be
100%. Data are reported as the means ± SD of 5 experiments. *P < 0.05 compared to control (ANOVA).
Table 1. Effect of indomethacin on the potency and
maximal effect induced by kinins on mouse abdominal
aorta rings.
Agonist pD2 (nM) Emax (% NE)
BK 7.1 ± 0.1 (15) 51 ± 2 (15)
BK + indomethacin ND 12.5 ± 0.7+ (3)
DBK 7.3 ± 0.2 (8) 30 ± 1* (8)
DBK + indomethacin ND 6 ± 2+ (3)
Bradykinin (BK)- and DesArg9BK (DBK)-induced iso-
metric contractile responses were assessed in the ab-
sence and in the presence of 1 µM indomethacin, a
cyclooxygenase inhibitor, preincubated for 20 min. The
responses to the agonists were calculated in relation to
the effect of 1 µM norepinephrine (NE) and the values
of pD2 (-log EC50, concentration of the agonist inducing
50% of the maximal response) and the Emax (maximal
effect) were obtained. Data are reported as means ±
SD with the number of experiments in parentheses. ND
= not determined. +P < 0.05 compared to the BK-
induced effect; *P < 0.05 compared to control (t-test).
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In order to evaluate the gene expression
of kinin B1 and B2 receptors in the mouse
aorta the amount of mRNA for both recep-
tors was analyzed using a quantitative RNA
assay. Kinin B1 receptor mRNA showed
detectable expression. This determination
revealed that the level of expression of
mRNA for the B1 receptor was lower than
that for the B2 receptor (Figure 3).
B2 receptors have been shown to mediate
endothelium-dependent vasodilation as well
as vasoconstriction (5,6). Therefore, the BK-
induced relaxing response of mouse aortic
rings was investigated. BK did not cause any
relaxation in the resting aortic preparations
with intact endothelium or on NE-induced
contraction. Instead of relaxation, the ad-
ministration of BK to NE-precontracted rings
produced further dose-dependent contrac-
tion, above the increased tension produced
by 1 µM NE (data not shown).
To investigate a possible role of NO re-
lease in the BK-induced contraction, an in-
hibitor of NO synthase activity was exam-
ined. Pre-incubation with 1 mM L-NAME
for 20 min did not enhance the contractions
induced by BK and DBK in aortic rings with
an intact endothelium. The presence of the
endothelium was confirmed pharmacologi-
cally by the acetylcholine-induced relaxing
effect on aortic rings precontracted with
NE.
The contractions induced by BK in mouse
aortic rings were blocked by preincubation
with 1 µM indomethacin for 20 min (Figure
4A). This effect was observed in endothe-
lium-intact as well as in endothelium-de-
nuded abdominal aorta. Similar results were
observed for the effect of DBK (Figure 4B).
Stimulation of mouse aorta with exog-
enous NO and sodium nitroprusside (SNP)
completely relaxed the NE-increased tone of
vascular tissue. SNP did not induce relax-
ation of the aorta under resting basal tonus.
The concentration-response curves for SNP
are shown in Figure 5 and the pD2 value was
calculated (7.7 ± 0.2).
Figure 3. Expression of mRNA
for kinin B1 and B2 receptors.
Gene expression of kinin B1 and
B2 receptors was determined by
real-time quantitative PCR. ß-
Actin was used as an internal
standard. The 2-∆CT parameter
was used to express the rela-
tive gene expression data. *P <
0.05 compared to B1 (t-test).
Figure 4. Effect of indomethacin
on the effect of bradykinin (BK)
and Des-Arg9BK (DBK) in
preparations of aortic rings. Cu-
mulative concentration-re-
sponse curves for BK (A) and
DBK (B) were obtained in the
absence and in the presence of
1 µM indomethacin, a cyclooxy-
genase inhibitor. Percent con-
traction was calculated from the
steady-state tension induced by
norepinephrine (NE). Data are
reported as the means ± SD of 4
experiments. *P < 0.05 com-
pared to control (ANOVA).
Figure 5. Sodium nitroprusside-
induced relaxation in norepi-
nephrine-precontracted rings of
mouse aorta. Percent relaxation
was calculated from the steady-
state tension induced by norepi-
nephrine. Data are reported as
means ± SD of 5 independent
determinations.
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Discussion
We assessed the role of B1 and B2 recep-
tors in mouse abdominal aorta using isomet-
ric force measurements. Our preliminary
studies had revealed a low responsiveness of
the thoracic aorta to the agonists BK and
DBK. The poor response to BK by the tho-
racic aorta in comparison with the response
of abdominal aorta was also observed in the
contractions induced by angiotensin II and
endothelin-1 in this tissue (6).
The present study showed that BK in-
duced a potent contractile response in the
abdominal aorta (51% of that induced by 1
µM NE) that was significantly inhibited by
the B2 receptor antagonist Icatibant, indicat-
ing that this agonist depends specifically on
the activation of this receptor. On the other
hand, DBK-induced contraction, whose ef-
ficacy was lower than that of BK (30% of
NE), was shown to be specifically mediated
by the B1 receptor which was antagonized
by the R-715 and DesArg9Leu8BK. By ana-
lyzing the gene expression of B1 and B2
receptors we could demonstrate B1 receptor
mRNA expression in freshly isolated mouse
aorta which indicated that DBK-induced
contractile responses were due to activation
of the constitutive B1 receptor rather than to
its up-regulation. The lower expression of
B1 receptor than B2 receptor mRNA was
correlated with the lower efficacy of DBK
compared to BK.
The contractile responses induced by BK
and DBK in the mouse aorta were similar to
those reported by Allogho et al. (3), who
showed that the mouse stomach contains
functional B1 and B2 receptors and that the
efficacy of BK was greater than that of DBK.
In contrast, the rat aorta has been re-
ported to be insensitive to DBK in vitro,
even after bacterial lipopolysaccharide pre-
treatment (7). More recent studies have
shown that rat aortic smooth muscle cells
bind the tritiated B1 receptor agonist 3H-
DBK and that B1 receptor mRNA was de-
tected (8). According to these observations,
rat aortic smooth muscle cells have the po-
tential to express B1 receptors but the ex-
pression level may not be high enough to
induce detectable contractile responses in
the isolated rat aorta.
Our finding that BK-induced contrac-
tions were not affected by endothelium re-
moval indicates that, in contrast to the va-
sodilator effect (9,10), the vasoconstriction
induced by kinins results from a direct ac-
tion on isolated mouse aortic smooth muscle.
In agreement with this result, BK-induced
contraction was not altered when the ab-
dominal aorta was treated with L-NAME.
This result suggests that NO-dependent va-
sodilation, which would antagonize part of
the vasoconstrictive effect of BK, can be
ruled out. It is noteworthy that endothelin-1-
induced contraction of the same preparation
was significantly reduced when L-NAME
was absent from the medium (11), whereas
this effect was not observed with angio-
tensin II-induced contraction (12).
The finding that the contractile responses
to BK and DBK were significantly reduced
by indomethacin in mouse endothelium-de-
nuded abdominal aorta indicates that these
responses are mostly mediated by vasocon-
strictor prostanoids. In this regard, it is inter-
esting to note that, as previously reported,
the prostanoids derived from the arachidon-
ic acid-cyclooxygenase pathway can be pro-
duced within the vascular smooth muscle
(13). Since the BK- and DBK-induced effect
was not completely blocked by the cyclo-
oxygenase inhibitor, the remaining response
could be ascribed to a direct rather than a
mediated effect of the peptides. However, a
possible involvement of other signaling path-
ways in this contractile effect cannot be
ruled out.
In contrast to the mouse abdominal aorta,
where kinins were unable to induce relax-
ation of NE-pre-contracted preparations, BK
induced concentration-dependent relaxation
in phenylephrine-pre-contracted rings of rat
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aorta, which was inhibited by Icatibant. This
vasorelaxation of endothelium-denuded rat
aorta was ascribed to the generation of cy-
clooxygenase products through activation
of B2 receptors on smooth muscle cells (14).
These results indicate that the effect of ki-
nins on vessels may differ considerably
among species.
The present study showed for the first
time that mouse aortic tissues express func-
tional constitutive kinin B1 and B2 receptors
localized within the vascular wall and that
BK and DBK induce contractile responses
which are mostly mediated by prostanoids.
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